Adhesives Research, Inc., founded in 1961 is a leading independent developer and manufacturer of custom pressure-sensitive adhesives, tapes, specialty films, coatings and laminates. Adhesives Research, Inc., is comprised of two unique businesses.

Adhesives Research (AR) continues to serve the medical, pharmaceutical, electronics, engineered tapes and splicing markets with one of a kind customized products designed and developed for international fortune 1000 companies who are leaders in their markets and who need a critical bonding component with additional functionality so that they may develop a product for specific applications.

The second business, ARx, LLC, is a custom developer and manufacturing partner for drug delivery platforms for the pharmaceutical and biotech industries. ARx, LLC specializes in transdermal patch drug delivery systems and drug-containing soluble films, including oral thin films and mucosal thin films for sublingual and buccal drug delivery. Together, AR and ARx, LLC provide custom solutions for the healthcare market.

North America

+1 800-445-6240
+1 717-235-7979

Europe

Ireland
+353 61 300 300

United Kingdom

+44 (0) 1371 878187

Singapore

+65 6774 9580

Shanghai

+86 21 6150 4358

Go to article: Home | A new era of buyers clubsGo to article: TSS ABGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Capsugel Company InsightGo to article: The pharma industry briefingGo to article: ICCI Company InsightGo to article: ICCIGo to article: Corbion PuracGo to article: Real world data: improving clinical trial outcomesGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: Understanding allergic reactions: chronicling the work of Dr Teruko IshizakaGo to article: Scandinavian HealthGo to article: Moehs Iberica SLGo to article: Swiss WorldCargoGo to article: Buyers’ clubs: the first step toward universal UK access to Orkambi?Go to article: TSS Company InsightGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Prescription dread: measuring psychiatric drugs against the alternativesGo to article: BEAGo to article: ZenatekGo to article: PfanstiehlGo to article: Herd health: agriculture’s role in the global AMR crisisGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Hapa Company InsightGo to article: ConcePTION: tackling the unknowns of medication in pregnancyGo to article: AEB Company Insight Go to article: AEBGo to article: Pfeiffer VacuumGo to article: From start-ups to the SIX Swiss Exchange – a Swiss success storyGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Cancer drug discovery: unravelling the mysteries of halichondrinGo to article: Centaur Clinical | Company InsightGo to article: IDMP is back: what next?Go to article: Charles Ischi Go to article: Adhesives ResearchGo to article: Emirates SkyCargoGo to article: Global labelling management: why does it continue to cause problems?Go to article: B&W TekGo to article: EventsGo to article: Dali Medical devicesGo to article: Spirax Sarco Company InsightGo to article: Spirax SarcoGo to article: Centaur ClinicalGo to article: Next issueGo to article: AralabGo to article: Baxter